Thu, 06 Nov 2025

Thu, 06 Nov 2025 Trump unveils deals to lower US weight-loss drug prices

US President Donald Trump announces agreements with drug makers Eli Lilly and Novo Nordisk.

* US President Donald Trump has announced deals with Eli Lilly and Novo Nordisk to lower the cost of popular weight-loss drugs.
* Consumers will pay between $245 and $350 per month for obesity drugs such as Wegovy and Zepbound, which typically cost over $1,000 without insurance or discounts.
* The deals will expand access to Medicare and Medicaid, with an estimated 10% of Medicare beneficiaries eligible for expanded access to GLP-1 drugs at a cost of $50.
* Eli Lilly will also escape tariffs for three years as part of the agreement.
* The Trump administration is pushing for "most-favoured nations" prices, which would align US drug prices with lower ones abroad.
* The deals are part of the administration's effort to lower pharmaceutical prices and improve affordability.
  >>